BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32142869)

  • 21. Cranial radiation therapy with hippocampus avoidance in lung cancer treatment: systematic review and meta-analysis.
    Zheng Y; You L; Feng B; Tang M; Na F
    Front Oncol; 2023; 13():1268754. PubMed ID: 37936606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification of symptomatic brain metastases by clinical and FDG PET parameters for selective use of prophylactic cranial irradiation in patients with extensive disease of small cell lung cancer.
    Chung JH; Kang SY; Wu HG; Seo YS; Kim DW; Kang KW; Kim HJ; Cheon GJ
    Radiother Oncol; 2020 Feb; 143():81-87. PubMed ID: 32044172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
    Le Péchoux C; Laplanche A; Faivre-Finn C; Ciuleanu T; Wanders R; Lerouge D; Keus R; Hatton M; Videtic GM; Senan S; Wolfson A; Jones R; Arriagada R; Quoix E; Dunant A;
    Ann Oncol; 2011 May; 22(5):1154-1163. PubMed ID: 21139020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
    Lou Y; Zhong R; Xu J; Qiao R; Teng J; Zhang Y; Zhang X; Chu T; Zhong H; Han B
    Thorac Cancer; 2020 May; 11(5):1239-1244. PubMed ID: 32142599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis.
    Mayinger M; Kraft J; Lohaus N; Weller M; Schanne D; Heitmann J; Willmann J; Wilke L; Krayenbuehl J; Tanadini-Lang S; Guckenberger M; Andratschke N
    Eur J Cancer; 2020 Jan; 124():194-203. PubMed ID: 31812935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Brain Changes Associated with Prophylactic Cranial Irradiation in Lung Cancer.
    Simó M; Vaquero L; Ripollés P; Gurtubay-Antolin A; Jové J; Navarro A; Cardenal F; Bruna J; Rodríguez-Fornells A
    J Thorac Oncol; 2016 Apr; 11(4):475-86. PubMed ID: 26804637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study.
    Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC
    Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic cranial irradiation in small cell lung cancer: an update.
    Chu X; Zhu Z
    Curr Opin Oncol; 2023 Jan; 35(1):61-67. PubMed ID: 36421007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.
    Chen Y; Li J; Hu Y; Zhang Y; Lin Z; Zhao Z; Jiao S
    Strahlenther Onkol; 2016 Dec; 192(12):905-912. PubMed ID: 27605237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
    Li J; Bentzen SM; Li J; Renschler M; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic cranial irradiation effect on survival in patients with small cell lung cancer: a comprehensive systematic review and meta-analysis.
    Maroufi SF; Fallahi MS; Kankam SB; Sheehan JP
    Neurosurg Focus; 2023 Aug; 55(2):E4. PubMed ID: 37527667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand?
    Crockett C; Belderbos J; Levy A; McDonald F; Le Péchoux C; Faivre-Finn C
    Lung Cancer; 2021 Dec; 162():96-105. PubMed ID: 34768007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.
    Gore EM; Hu C; Sun AY; Grimm DF; Ramalingam SS; Dunlap NE; Higgins KA; Werner-Wasik M; Allen AM; Iyengar P; Videtic GMM; Hales RK; McGarry RC; Urbanic JJ; Pu AT; Johnstone CA; Stieber VW; Paulus R; Bradley JD
    J Thorac Oncol; 2017 Oct; 12(10):1561-1570. PubMed ID: 28648948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
    Bernhardt D; Bozorgmehr F; Adeberg S; Opfermann N; von Eiff D; Rieber J; Kappes J; Foerster R; König L; Thomas M; Debus J; Steins M; Rieken S
    Lung Cancer; 2016 Nov; 101():76-81. PubMed ID: 27794411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic cranial irradiation in small cell lung cancer: a single institution experience.
    Naidoo J; Kehoe M; Sasiadek W; Hacking D; Calvert P
    Ir J Med Sci; 2014 Mar; 183(1):129-32. PubMed ID: 23760883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
    Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
    Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
    Gondi V; Paulus R; Bruner DW; Meyers CA; Gore EM; Wolfson A; Werner-Wasik M; Sun AY; Choy H; Movsas B
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):656-64. PubMed ID: 23597420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.
    Zeng H; Hendriks LEL; van Geffen WH; Witlox WJA; Eekers DBP; De Ruysscher DKM
    Cancer Treat Rev; 2020 Aug; 88():102025. PubMed ID: 32512415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
    Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
    Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early versus late prophylactic cranial irradiation in patients with extensive small cell lung cancer.
    Chen Y; Li J; Zhang Y; Hu Y; Zhang G; Yan X; Lin Z; Zhao Z; Jiao S
    Strahlenther Onkol; 2018 Oct; 194(10):876-885. PubMed ID: 29774395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.